Pacific Biosciences of California, Inc. PACB, popularly known as PacBio, delivered an adjusted loss per share of 20 cents in ...

For the quarter ended December 2024, Pacific Biosciences of California (PACB) reported revenue of $39.22 million, down 32.8% over the same period last year. EPS came in at -$0.20, compared to -$0.27 ...

MENLO PARK, Calif. (AP) — MENLO PARK, Calif. (AP) — Pacific Biosciences of California Inc. (PACB) on Thursday reported fourth-quarter profit of $3.6 million. The Menlo Park, California-based company ...

Canaccord reiterates a Buy rating on PacBio (PACB) with a $3 price target following the company’s Q4 report. The firm says that although PacBio ...

Todd Friedman; Senior Director of Investor Relations; Pacific Biosciences of California Inc Christian Henry; President, Chief Executive Officer, Director; Pacific Biosciences of California Inc Michele ...

Pacific Biosciences of California Inc (NASDAQ:PACB) is set to release its Q4 2024 earnings on Feb 13, 2025. The consensus ...

Pre-earnings options volume in Pac Bio is 4.3x normal with calls leading puts 7:5. Implied volatility suggests the market is anticipating a ...

Pacific Biosciences of California, Inc. ( NASDAQ: PACB) Q4 2024 Earnings Conference Call February 13, 2025 4:30 PM ET Todd Friedman - Senior Director, Finance and Investor Relations Christian Henry - ...